-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on MDxHealth, Maintains $7 Price Target

Benzinga·12/23/2025 11:52:06
语音播报
BTIG analyst Mark Massaro reiterates MDxHealth (NASDAQ:MDXH) with a Buy and maintains $7 price target.